IHAB HAJJAR to Neuroprotection
This is a "connection" page, showing publications IHAB HAJJAR has written about Neuroprotection.
Connection Strength
0.045
-
A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairment. Brain. 2022 06 30; 145(6):1924-1938.
Score: 0.045
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.